BioNTech SE — Investor Relations & Filings
BioNTech SE is a global biotechnology company pioneering novel therapies for cancer and infectious diseases. The company leverages its deep expertise in immunology to develop a diverse portfolio of therapeutic platforms. Its oncology pipeline includes mRNA-based cancer immunotherapies, next-generation immunomodulators, and targeted therapies, with a strategy focused on creating synergistic combinations. In infectious diseases, BioNTech applies its proprietary mRNA technology to develop vaccines, most notably co-developing the first authorized mRNA-based vaccine for COVID-19. The company's core mission is to translate scientific research into innovative treatments that harness the power of the immune system to improve or establish new standards of care for patients globally.
Recent filings
| Filing | Released | Lang | Actions |
|---|---|---|---|
| Regulatory Filings 2024 | 2024-10-07 | English | |
| Regulatory Filings 2024 | 2024-10-04 | English | |
| Regulatory Filings 2024 | 2024-10-03 | English | |
| Regulatory Filings 2024 | 2024-10-03 | English | |
| Regulatory Filings 2024 | 2024-10-01 | English | |
| 6-K | 2024-10-01 | English |
| ID | Filing | Released | Lang | Actions | |
|---|---|---|---|---|---|
|
2024
15 filings
| |||||
| 13180684 | Regulatory Filings 2024 | 2024-10-07 | English | ||
| 13180685 | Regulatory Filings 2024 | 2024-10-04 | English | ||
| 13180686 | Regulatory Filings 2024 | 2024-10-03 | English | ||
| 13180687 | Regulatory Filings 2024 | 2024-10-03 | English | ||
| 13180692 | Regulatory Filings 2024 | 2024-10-01 | English | ||
| 13180690 | 6-K | 2024-10-01 | English | ||
| 13180691 | Regulatory Filings 2024 | 2024-09-30 | English | ||
| 13180694 | Regulatory Filings 2024 | 2024-09-27 | English | ||
| 13180693 | Regulatory Filings 2024 | 2024-09-26 | English | ||
| 13180695 | 6-K | 2024-09-20 | English | ||
| 13180696 | Regulatory Filings 2024 | 2024-09-19 | English | ||
| 13180697 | Regulatory Filings 2024 | 2024-09-17 | English | ||
| 13180698 | Regulatory Filings 2024 | 2024-09-16 | English | ||
| 13180699 | Regulatory Filings 2024 | 2024-09-16 | English | ||
| 13180700 | Regulatory Filings 2024 | 2024-09-13 | English | ||
Financials
We couldn't load the financials
No data available yet
We have extracted financials for BioNTech SE, but not for this combination of statement and period. Try a different combination.
| Line item | ! |
|---|---|
Market data
Market data not available
Price history
Peer group · Manufacture of pharmaceuticals, medicinal chemical and botanical products
| Company | Ticker | Country | Sector |
|---|---|---|---|
|
13260917 Canada Inc.
Biotech developing oral small molecules to restore muscle s…
|
MSCL | CA | Manufacturing |
|
1608557 Ontario Inc.
Biopharmaceutical company dedicated to R&D, discovery, and …
|
OTROQ | CA | Manufacturing |
|
3B BlackBio Dx Limited
Develops molecular diagnostic kits for oncology, infectious…
|
3BBLACKBIO | IN | Manufacturing |
|
3D Medicines Inc.
Commercial-stage biopharma specializing in next-generation …
|
1244 | HK | Manufacturing |
|
3SBio Inc.
Biopharmaceutical enterprise specializing in R&D, productio…
|
1530 | KY | Manufacturing |
|
4BASEBIO PLC
Manufactures GMP-grade synthetic DNA for next-generation th…
|
4BB | GB | Manufacturing |
|
4D Molecular Therapeutics, Inc.
Develops genetic medicines using AAV vectors for ophthalmol…
|
FDMT | US | Manufacturing |
|
4Front Ventures Corp.
Vertically integrated cannabis operator managing cultivatio…
|
FFNT | CA | Manufacturing |
|
4SC AG
Biopharmaceutical company with no products under developmen…
|
VSC | DE | Manufacturing |
|
60 DEGREES PHARMACEUTICALS, INC.
Develops and commercializes medicines for infectious diseas…
|
SXTP | US | Manufacturing |
BioNTech SE via the API
Pull this company's filings, identifiers, and metadata as JSON or Markdown. Authenticate with your API key, then query by company ID, ISIN, or LEI. Full schema documented in the OpenAPI spec.
Endpoints
| GET | /api/companies/30236/ | Company identity, sector, listing, identifiers |
| GET | /api/filings/?company=30236 | Paginated list of all filings (filterable by type, date, language) |
| GET | /api/filings/{id}/ | Single filing — metadata, document URL, processing status |
| GET | /api/filings/{id}/markdown/ | Filing content as Markdown (PDF → text/tables/figures) |
| GET | /api/isins/?company=30236 | All ISINs registered to this company |
| GET | /api/filing-types/ | Reference: every filing-type code + category |
cURL
$ curl https://api.financialreports.eu/api/filings/?company=30236 \ -H "x-api-key: $FR_API_KEY" \ -H "Accept: application/json"
Python
import requests r = requests.get( "https://api.financialreports.eu/api/filings/", params={"company": 30236}, headers={"x-api-key": API_KEY}, ) filings = r.json()["results"]
MCP server
// MCP server URL https://mcp.financialfilings.com/mcp // Once connected, the LLM can query this company directly: "Pull the latest 5 filings for BioNTech SE (id: 30236)"
Report missing filing
Can't find a specific document? Let us know and we'll add it within 24 hours.